When Steven Paget published his theory of "seed and soil" in1889,1 the idea of hematogenous tumor-cell dissemination wasborn. More than a century later, with the use of molecular tools,new clinical findings have resulted in explanations of hither-tounexplainable phenomena, such as that donor-derived cancer inrecipient organ allografts2 and viable single tumor cells insecondary organs were both the descendants of a known primarytumor3 and the potential precursors of subsequent metastasis.4Now, as shown by Cristofanilli et al.5 in this issue of theJournal, a laboratory assay of circulating tumor cells enablesus to predict a . . . [Full Text of this Article]
Source Information
From the Department of Gynecology and Obstetrics and the Breast Health Center, Innsbruck Medical University, Innsbruck, Austria.
This article has been cited by other articles:
Schiller, J. H.
(2008). Noninvasive Monitoring of Tumors. NEJM
359: 418-420
[Full Text]
Maheswaran, S., Sequist, L. V., Nagrath, S., Ulkus, L., Brannigan, B., Collura, C. V., Inserra, E., Diederichs, S., Iafrate, A. J., Bell, D. W., Digumarthy, S., Muzikansky, A., Irimia, D., Settleman, J., Tompkins, R. G., Lynch, T. J., Toner, M., Haber, D. A.
(2008). Detection of Mutations in EGFR in Circulating Lung-Cancer Cells. NEJM
359: 366-377
[Abstract][Full Text]
Muller, V., Stahmann, N., Riethdorf, S., Rau, T., Zabel, T., Goetz, A., Janicke, F., Pantel, K.
(2005). Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity. Clin. Cancer Res.
11: 3678-3685
[Abstract][Full Text]